4
Changes in Ownership
Fulgent Genetics, Inc. Filed Acc 0000950170-24-030261
Options or other derivatives
- Chief Executive Officer disposed of 1,000,000 shares (other)
- Chief Executive Officer acquired 1,000,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Hsieh Ming · Chief Executive Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-08 | Other disposition : show line 1 in the form Forward sale contract (obligation to sell) | −1,000,000 | 0 | I |
| 2024-03-08 | Other acquisition : show line 2 in the form Forward sale contract (obligation to sell) | +1,000,000 | 1,000,000 | I |
Loading xslF345X05/ownership.xml…